10 May 2018. Hg today announces an investment into MediFox, a leading provider of software solutions to outpatient and inpatient care providers and therapy practices in Germany. The investment follows an exit from private equity funds managed by Equity Capital Management (“ECM”).

The closing of the transaction is subject to regulatory approval and the terms are not disclosed.

Founded in 1994, MediFox is a leading provider of software solutions to over 6,000 ambulatory care services, elderly care homes and therapists in Germany. Its software solutions support care providers with key services including resource and route planning, care and support documentation, management information systems, as well as billing, factoring and administration services. It is headquartered in Hildesheim, Germany and employs 265 people.

The investment, which will be made from the Mercury 2 Fund, recognises MediFox’s attractive business model characteristics, being a well-established player with a strong position in a fragmented sector,  showing a positive underlying growth trajectory whilst also having a ‘mission-critical’ product offering, a robust financial profile and a highly competent management team.

Stefan Margolis, Director at Hg, and Kai Romberg, Partner at Hg, said: “We have been following the progress and success of MediFox for many years and recognise the strength of the business and the opportunity for further growth, both organically and through acquisitions. Our expertise and focus on software and Healthcare IT, following previous investments in Allocate Software and Evaluate, along with our strong presence in Germany, means we are well placed to support management in taking the business on to its next phase of growth.”

Christian Städtler and Dr. Thorsten Schliebe, both Managing Directors at MediFox, said: “We want to thank ECM for their strong support over the last 5 years. We look forward to leveraging Hg’s experience and track record in working with software and healthcare companies to further strengthen and expand MediFox’s position, as we continue our journey towards further growth.”